218 related articles for article (PubMed ID: 30235216)
1. Epidemiological and economic burden of potentially HPV-related cancers in France.
Abramowitz L; Lacau Saint Guily J; Moyal-Barracco M; Bergeron C; Borne H; Dahlab A; Bresse X; Uhart M; Cancalon C; Catella L; Bénard S
PLoS One; 2018; 13(9):e0202564. PubMed ID: 30235216
[TBL] [Abstract][Full Text] [Related]
2. The economic burden of human papillomavirus-related precancers and cancers in Sweden.
Östensson E; Silfverschiöld M; Greiff L; Asciutto C; Wennerberg J; Lydrup ML; Håkansson U; Sparén P; Borgfeldt C
PLoS One; 2017; 12(6):e0179520. PubMed ID: 28651012
[TBL] [Abstract][Full Text] [Related]
3. Economic burden of HPV-related cancers in France.
Borget I; Abramowitz L; Mathevet P
Vaccine; 2011 Jul; 29(32):5245-9. PubMed ID: 21616117
[TBL] [Abstract][Full Text] [Related]
4. The healthcare costs of treating human papillomavirus-related cancers in Norway.
Hylin H; Thrane H; Pedersen K; Kristiansen IS; Burger EA
BMC Cancer; 2019 May; 19(1):426. PubMed ID: 31064346
[TBL] [Abstract][Full Text] [Related]
5. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
Chaturvedi AK
J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
[TBL] [Abstract][Full Text] [Related]
6. Economic burden of non-cervical cancers attributable to human papillomavirus: a European scoping review.
Préaud E; Largeron N
J Med Econ; 2013; 16(6):763-76. PubMed ID: 23565814
[TBL] [Abstract][Full Text] [Related]
7. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
Nelson RA; Lai LL
Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917
[TBL] [Abstract][Full Text] [Related]
8. A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France.
Bresse X; Adam M; Largeron N; Roze S; Marty R
Hum Vaccin Immunother; 2013 Apr; 9(4):823-33. PubMed ID: 23563511
[TBL] [Abstract][Full Text] [Related]
9. The economic burden of human papillomavirus infection-associated diseases in the Republic of Korea, 2002-2015.
Ki M; Choi HY; Han M; Oh JK
Vaccine; 2018 Jul; 36(31):4633-4640. PubMed ID: 29961603
[TBL] [Abstract][Full Text] [Related]
10. Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimates.
Ong KJ; Checchi M; Burns L; Pavitt C; Postma MJ; Jit M
Sex Transm Infect; 2019 Feb; 95(1):28-35. PubMed ID: 30674687
[TBL] [Abstract][Full Text] [Related]
11. Infection of human papillomaviruses in cancers of different human organ sites.
Shukla S; Bharti AC; Mahata S; Hussain S; Kumar R; Hedau S; Das BC
Indian J Med Res; 2009 Sep; 130(3):222-33. PubMed ID: 19901431
[TBL] [Abstract][Full Text] [Related]
12. Incremental healthcare resource utilization and costs for patients with cervical, vaginal, vulvar, anal, and oropharyngeal cancer in the United States.
Prabhu V; Kathe N; Saxena K; Walia A; Markan R; Myers E; Einstein M
Curr Med Res Opin; 2021 Sep; 37(9):1599-1607. PubMed ID: 34018457
[TBL] [Abstract][Full Text] [Related]
13. Update of HPV-associated female genital cancers in the United States, 1999-2004.
Watson M; Saraiya M; Wu X
J Womens Health (Larchmt); 2009 Nov; 18(11):1731-8. PubMed ID: 19951205
[TBL] [Abstract][Full Text] [Related]
14. Presumed previous human papillomavirus (HPV) related gynecological cancer in women diagnosed with anal cancer in the province of Ontario.
Jiménez W; Paszat L; Kupets R; Wilton A; Tinmouth J
Gynecol Oncol; 2009 Sep; 114(3):395-8. PubMed ID: 19501390
[TBL] [Abstract][Full Text] [Related]
15. The evolution of HPV-related anogenital cancers reported in Quebec - incidence rates and survival probabilities.
Louchini R; Goggin P; Steben M
Chronic Dis Can; 2008; 28(3):99-106. PubMed ID: 18341764
[TBL] [Abstract][Full Text] [Related]
16. Burden of Disease of Human Papillomavirus (HPV): Hospitalizations in the Marche and Veneto Regions. An observational study.
Mennini FS; Fabiano G; Marcellusi A; Sciattella P; Saia M; Cocchio S; Baldo V
Clin Drug Investig; 2018 Feb; 38(2):173-180. PubMed ID: 29081028
[TBL] [Abstract][Full Text] [Related]
17. [HPV DNA genotyping: A study of anogenital, head and neck and skin cancers in a population from west Algerian. HPV detection in different cancers from an Algerian population].
Nahet A; Boublenza L; Hassaine H; Masdoua N; Prétet JL; Belglaiaa E; Mougin C
Bull Cancer; 2016 May; 103(5):455-60. PubMed ID: 27085765
[TBL] [Abstract][Full Text] [Related]
18. Vulvar and vaginal cancers and dysplasia in France--an analysis of the hospital medical information system (PMSI) database.
Rémy V; Mathevet P; Vainchtock A
Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):210-4. PubMed ID: 19735968
[TBL] [Abstract][Full Text] [Related]
19. 9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV.
Pitisuttithum P; Velicer C; Luxembourg A
Expert Rev Vaccines; 2015; 14(11):1405-19. PubMed ID: 26366475
[TBL] [Abstract][Full Text] [Related]
20. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.
Riethmuller D; Jacquard AC; Lacau St Guily J; Aubin F; Carcopino X; Pradat P; Dahlab A; Prétet JL
BMC Public Health; 2015 May; 15():453. PubMed ID: 25934423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
